Stroke drug demonstrates safety in clinical trial

Stroke drug demonstrates safety in clinical trial

First published on ScienceDaily

A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, the most common type of stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug invented at The Scripps Research Institute (TSRI). The trial results, announced by pharmaceutical company ZZ Biotech, also show that 3K3A-APC substantially reduced hemorrhage volume and hemorrhage incidence in patients.

“These results lay the groundwork for the next steps toward FDA approval,” says John Griffin, PhD, professor at TSRI, whose team invented 3K3A-APC. (more…)

The first Slovenian Stroke Club Forum in 2018

The first Slovenian Stroke Club Forum in 2018

Written by Jelka Janša, Slovenian Stroke Support Organisation

On February 12 -13, 2018 the Slovenian Stroke Club Forum took place at the Topolšica Thermal Spa. The first Slovenian forum was launched in the late 90-ties, followed by the positive examples from the Stroke association in the United Kingdom. In Slovenia, since then, each year there will be between two to four forums organised, depending on the content, size and amount of activities within the organisation. After forum being convened by the president of the Slovenian Stroke Support Organisation, a special chair is appointed for each forum.

Forum consist of the presidents from the local stroke clubs and board members. Forum itself supports the operational activities of the organisation, discusses immediate and future plans, liaise clubs’ activities with relevant local institutions and local associations, covers communication with local media, enables local fundraising, supports visits among the clubs. Usually, as an add-on, there would also be a professional lecture on a topic of interest to the forum. This time the topic was the Burden of stroke among stroke survivors and their relatives in Slovenia.

The first Stroke Club Forum in 2018 was convened by Mr. Milan Čuček, the president and Mrs. Tatjana Erjavec, the vice-president of the Slovenian Stroke Support Organisation. The participants, presidents from local clubs and some board members, were discussing and analyzing activities in 2017, and annual and long term plans of the Organisation. Immediate action plans have been targeted toward improvement of the ongoing monthly clubs’ meeting. Further they were exploring ways to increase membership and expanding fundraising capabilities. In addition, there are two activities planned for May 2018; organized events to mark the European Stroke day and promotion of »The Stroke Action Plan«document in Slovenia.
Overall, forum was dynamic, stimulating and allowed plenty of constructive discussion.

 

Slovenian Stroke Club Forum, photo by Združenje bolnikov s cerebrovaskularno boleznijo

Stroke drug demonstrates safety in clinical trial

Stretchable electronics a ‘game changer’ for stroke recovery treatment

First published on ScienceDaily

A groundbreaking new wearable designed to be worn on the throat could be a game-changer in the field of stroke rehabilitation.

Developed in the lab of Northwestern University engineering professor John A. Rogers, in partnership with Shirley Ryan AbilityLab, the sensor is the latest in Rogers’ growing portfolio of stretchable electronics that are precise enough for use in advanced medical care and portable enough to be worn outside the hospital, even during extreme exercise. (more…)

Stroke drug demonstrates safety in clinical trial

Short kids may have higher future stroke risk

First published on ScienceDaily

Being a short kid is associated with increased risk of having a stroke in adulthood, according to Danish research published in Stroke, an American Heart Association journal.

A prospective study examined data on more than 300,000 Danish schoolchildren — born between 1930-1989 who were examined at ages 7, 10 and 13. Researchers noted that boys and girls who were 2 to 3 inches shorter than average for their age were at increased risk of clot-related (ischemic) stroke in adult men and women and of bleeding stroke in men. (more…)

Stroke drug demonstrates safety in clinical trial

Testimonial Exhibition at the World Stroke Congress October 2018

Written by Sarah Belson, published on worldstrokeorganization.blogspot.com

We want to make sure that the voices of people affected by stroke are heard throughout the Congress in an exhibition of stroke survivor, family and caregiver testimonials.

The 11th World Stroke Congress will focus on the latest developments in stroke prevention, acute management and restorative care after stroke. Reducing the burden of stroke on people with lived experience and their family and care givers drives everything the World Stroke Organization does.

In previous years the visibility of people with lived experience of stroke has been promoted through art exhibitions, both physical and online, and a hobbies ebook. (more…)